Recovery After Laparoscopic Hysterectomy With Deep Neuromuscular Blockade and Low Intra-abdominal Pressure
NCT ID: NCT01722097
Last Updated: 2015-10-21
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
110 participants
INTERVENTIONAL
2012-11-30
2014-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Primary hypothesis:
Deep neuromuscular blockade and low intra-abdominal pressure (8 mmHg) reduces postoperative pain compared to moderate neuromuscular blockade and intra-abdominal pressure (12 mmHg).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transmuscular Quadratus Lumborum Block for Total Laparoscopic Hysterectomy.
NCT03650998
Deep Neuromuscular Block Affect the Quality of Recovery After Laparoscopic Hysterectomy
NCT06469866
Paracervical Block in Laparoscopic Hysterectomy
NCT03792009
Analgesic Effects of US Bilateral Rectus Sheath Block for Laparoscopic GY Surgery
NCT02476799
Transversus Abdominis Plane Block After Robot-assisted Laparocopic Hysterectomy
NCT01504386
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Deep neuromuscular blockade
Drug: Rocuronium Intravenous use: 0.3 mg/kg before intubation and 0,7 mg after intubation followed by infusion with 0,3-0,4 mg/kg/h Other Name: Esmeron
Rocuronium
Moderate neuromuscular blockade
Drug: Rocuronium Intravenous use: 0,3 mg/kg followed by NaCl-infusion Other Name: Esmeron
placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Rocuronium
placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Can read and understand Danish
* Informed consent
Exclusion Criteria
* Known allergy to medications that are included in the project
* Severe renal disease, defined by S-creatinine \> 0,200 mmol/L, GFR \< 30ml/min or hemodialysis)
* Neuromuscular disease that may interfere with neuromuscular data
* Lactating
* Impaired liver function
* Indication for rapid sequence induction (esophageal reflux/ hiatus hernia/other cause)
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Herlev Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Matias Vested Madsen
research assistent, MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mona Gätke, MD, ph.d.
Role: STUDY_CHAIR
Department of anesthesia, Herlev Hospital
Matias Vested Maden, MD
Role: PRINCIPAL_INVESTIGATOR
Department of anesthesia, Herlev Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of anesthesia and department of minimal invasive gynecology, Aleris-Hamlet
Søborg, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Madsen MV, Istre O, Springborg HH, Staehr-Rye AK, Rosenberg J, Lund J, Gatke MR. Deep neuromuscular blockade and low insufflation pressure during laparoscopic hysterectomy. Dan Med J. 2017 May;64(5):A5364.
Madsen MV, Istre O, Staehr-Rye AK, Springborg HH, Rosenberg J, Lund J, Gatke MR. Postoperative shoulder pain after laparoscopic hysterectomy with deep neuromuscular blockade and low-pressure pneumoperitoneum: A randomised controlled trial. Eur J Anaesthesiol. 2016 May;33(5):341-7. doi: 10.1097/EJA.0000000000000360.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2012-003787-51
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
NMBDK2012
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.